ProMIS Neurosciences Files 2024 Annual Report
Ticker: PMN · Form: 10-K · Filed: 2025-03-31T00:00:00.000Z
Sentiment: neutral
Topics: annual-report, pharmaceuticals, sec-filing
TL;DR
ProMIS Neurosciences filed its 2024 10-K. Check financials.
AI Summary
ProMIS Neurosciences Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as AMORFIX LIFE SCIENCES LTD, is based in Toronto and operates in the Pharmaceutical Preparations sector. The filing details its financial performance and business operations for the period.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of ProMIS Neurosciences' financial health and strategic direction for the past fiscal year.
Risk Assessment
Risk Level: medium — As a company in the pharmaceutical preparations sector, ProMIS Neurosciences is subject to significant regulatory, research and development, and market risks.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations)
- 001-41429 — SEC File Number (SEC filing identifier)
Key Players & Entities
- ProMIS Neurosciences Inc. (company) — Filer of the 10-K
- AMORFIX LIFE SCIENCES LTD (company) — Former name of ProMIS Neurosciences Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-31 (date) — Filing date
- Toronto (location) — Company headquarters
FAQ
What was the primary business of ProMIS Neurosciences Inc. during the fiscal year ending December 31, 2024?
The company operates in the Pharmaceutical Preparations sector, as indicated by its SIC code 2834.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 31, 2025.
What is the company's principal place of business?
The company's business address is Suite 200, 1920 Yonge Street, Toronto, A6, M4S 3E2.
Has ProMIS Neurosciences Inc. operated under any other names previously?
Yes, the company was formerly known as AMORFIX LIFE SCIENCES LTD, with a name change date of August 31, 2006.
What is the SEC file number associated with this filing?
The SEC file number is 001-41429.
From the Filing
0001558370-25-004068.txt : 20250331 0001558370-25-004068.hdr.sgml : 20250331 20250331070038 ACCESSION NUMBER: 0001558370-25-004068 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 108 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250331 DATE AS OF CHANGE: 20250331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProMIS Neurosciences Inc. CENTRAL INDEX KEY: 0001374339 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41429 FILM NUMBER: 25788798 BUSINESS ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 BUSINESS PHONE: 416-847-6898 MAIL ADDRESS: STREET 1: SUITE 200, 1920 YONGE STREET CITY: TORONTO STATE: A6 ZIP: M4S 3E2 FORMER COMPANY: FORMER CONFORMED NAME: AMORFIX LIFE SCIENCES LTD DATE OF NAME CHANGE: 20060831 10-K 1 pmn-20241231x10k.htm 10-K PROMIS NEUROSCIENCES INC._December 31, 2024 0001374339 2024 FY false 0 0 0 0 Unlimited Unlimited Unlimited Unlimited P2Y P2Y 0 http://fasb.org/us-gaap/2023#NonoperatingIncomeExpense http://fasb.org/us-gaap/2023#NonoperatingIncomeExpense http://www.promisneurosciences.com/20241231#GainLossFromChangeInFairValueOfFinancialInstruments P12M P18M 1.15 0001374339 pmn:August2023PrivatePlacementMember 2023-08-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-12-31 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-10-23 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputSharePriceMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2024-07-26 0001374339 pmn:TrancheaAndBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2024-07-26 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001374339 pmn:CanadianDollarDenominatedWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2023-12-31 0001374339 us-gaap:MeasurementInputRiskFreeInterestRateMember pmn:August2023PrivatePlacementMember 2023-08-31 0001374339 us-gaap:MeasurementInputPriceVolatilityMember pmn:August2023PrivatePlacementMember 2023-08-31 0001374339 us-gaap:MeasurementInputExpectedTermMember pmn:August2023PrivatePlacementMember 2023-08-31 0001374339 us-gaap:InvestmentCreditMember 2024-12-31 0001374339 pmn:NonCapitalLossCarryforwardMember 2024-12-31 0001374339 us-gaap:CommonStockMember pmn:July2024PipeFinancingMember 2024-01-01 2024-12-31 0001374339 pmn:Series2PreferredSharesMember us-gaap:PreferredStockMember 2024-01-01 2024-12-31 0001374339 us-gaap:RetainedEarningsMember 2024-12-31 0001374339 us-gaap:AdditionalPaidInCapitalMemb